Director/PDMR Shareholding

RNS Number : 6860N

GlaxoSmithKline PLC

01 February 2016

 

GlaxoSmithKline plc

 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibilities or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the 'Plan') notified GlaxoSmithKline plc ('GSK') on 28 January 2016 that the under-mentioned Directors, Persons Discharging Managerial Responsibilities ('PDMR') and Connected Persons acquired notional Ordinary Shares at a price of 1380.50 pence per Ordinary Share and American Depositary Shares ('ADSs') at a price of $40.28 per ADS, following the notional re-investment of the dividend paid to shareholders on 14 January 2016.

Director/PDMR	Ordinary Shares	ADSs
Sir Andrew Witty	19,386.598
Dr M M Slaoui		5,593.782
Mr S Dingemans	8,420.745
Mr R G Connor	3,776.009
Mr N Hirons	605.055	205.414
Mr S A Hussain	7,915.467
Mr D S Redfern	2,871.479
Ms C Thomas	3,990.411
Mr P C Thomson	2,037.648
Mr D E Troy		3,479.925
Dr P J T Vallance	8,497.018
Ms E Walmsley	5,746.265
Mrs V A Whyte	535.716

Connected Person	Ordinary Shares	ADSs
Dr K Slaoui (Connected Person to Dr M M Slaoui)		90.488
Mrs K Thomson (Connected Person to Mr P C Thomson)	50.565

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

V A Whyte

Company Secretary

1 February 2016

 

END

 

 

RDSEFLFBQLFXBBV